VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹459 Cr | ₹319 Cr | ₹267 Cr | ₹278 Cr | ₹301 Cr |
What is the latest Total Non-Current Assets ratio of VENUS REMEDIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹459 Cr |
| Mar2025 | ₹319 Cr |
| Mar2024 | ₹267 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹301 Cr |
How is Total Non-Current Assets of VENUS REMEDIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹459 Cr | 43.82 | |
| Mar2025 | ₹319 Cr | 19.27 | |
| Mar2024 | ₹267 Cr | -3.93 | |
| Mar2023 | ₹278 Cr | -7.59 | |
| Mar2022 | ₹301 Cr | - | |
Compare Total Non-Current Assets of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,071.9 Cr | -6.3% | -12.9% | 210.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -6.3% |
-12.9% |
210.1% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses